Edison Investment Research publishes Executive interview with Sten R. Sörensen, CEO, Cereno Scientific
Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that an executive interview has been published by equity research company Edison Investment Research, who earlier today published its first, in-depth research on the company.In conjunction with the research report published on Thursday the 22nd of February, Edison released a video interview, where Soo Romanoff, Healthcare Managing Director of Edison Group, interviews Sten Sörensen, CEO of Cereno Scientific, who discusses the company’s